Citation APA
Suarez-Carmona, M., Hampel, M., Zhang, X.-W., Pöchmann, A., Grauling-Halama, S., Valous, N., Charoentong, P., Ferber, D., Wissfeld, J., Höflich, A., Goriely, S., Detavernier, A., Azouz, A., Rongvaux, A., Zukunft, S., Fleming, I., Okun, J. G., Baracos, V., Heikenwalder, M., Zitvogel, L., Xu, X., Xu, C., Volkmar, M., Schraivogel, D., Steinmetz, L. L., Hamanishi, J., Mandai, M., Gaida, M., Mokry, T., Nattenmüller, J., Sedlaczek, O., Monje, N., Schwab, R., Hasenburg, A., Mavratzas, A., Boger, R. J., Marmé, F., Schott, S., & Halama, N. (2026). Harnessing lipid-driven immunometabolic pathways in omental metastases to enhance immunotherapy in patients with ovarian cancer. Signal Transduction and Targeted Therapy, 11(1). doi:10.1038/s41392-026-02594-8
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/406277